Provided by Tiger Trade Technology Pte. Ltd.

Alger Mid Cap 40 ETF

22.79
+0.11630.51%
Post-market: 22.790.00000.00%16:15 EDT
Volume:12.42K
Turnover:281.62K
Market Cap:148.72M
PE:- -
High:22.80
Open:22.48
Low:22.48
Close:22.68
52wk High:24.82
52wk Low:18.46
Shares:6.53M
Float Shares:6.53M
Volume Ratio:0.78
T/O Rate:0.19%
Dividend:0.04
Dividend Rate:0.18%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Meta (META) Launches Subscription AI Service as It Looks to Monetize the Technology

TIPRANKS
·
Sep 16

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU
·
Sep 16

Meta Prepares Homegrown AI Chips for Data Centers to Reduce Nvidia Hardware Reliance and Lower Energy Costs

TIPRANKS
·
Sep 15

Oracle’s (ORCL) Q1 Still Didn’t Prove the Value of Its Spending Spree

TIPRANKS
·
Sep 15

Wall Street Debates the Fate of Trillion-Dollar Capex Amid AI 'Slowdown' Claims

Deep News
·
Sep 15

Citi Picks Its Top Memory Stocks

TIPRANKS
·
Sep 15

AI Chip Startup Euclyd Sets Sights on Toppling Nvidia as It Raises €200M in New Funds

TIPRANKS
·
Sep 15

Tech Sector Rattled as Industry Leaders Urge Slower AI Development Pace

Deep News
·
Sep 15

Barclays downgrades Scholar Rock on valuation after FDA approval

TIPRANKS
·
Sep 15

Global Asset Manager AllianceBernstein Downplays AI Slowdown Fears, Citing Unchanged Tech Financing Plans

Stock News
·
Sep 15

Wall Street on Edge as AI Pioneers Urge Caution, Raising Fears of a Spending Slowdown

Stock News
·
Sep 15

Westpac Flags Strategic Update on Data, Digital and AI Focus

TIPRANKS
·
Sep 15

AI Daily: Trump calls fears of AI destroying humanity ‘a hoax’

TIPRANKS
·
Sep 15

Anthropic Still Likely to Go Public This Year Despite AI Backlash

TIPRANKS
·
Sep 14

Biofrontera announces FDA approval of Ameluz supplemental new drug application

TIPRANKS
·
Sep 14

Scholar Rock Wins FDA Approval for SMA Therapy

TIPRANKS
·
Sep 14

Scholar Rock price target raised to $84 from $76 at BMO Capital

TIPRANKS
·
Sep 14

Does a Slower AI Development Pace Signal Peak Capital Spending? Not Necessarily, Say Some Analysts

Deep News
·
Sep 14

Goldman Sachs 2026 Communications and Technology Conference Highlights: AI Transitions From Experimentation to Deployment, Capital Expenditure Expected to Remain Elevated

Stock News
·
Sep 14

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

TIPRANKS
·
Sep 14